Symbols / KTTA $0.77 -0.16% Pasithea Therapeutics Corp.

Healthcare • Biotechnology • United States • NCM
KTTA Chart
About

Pasithea Therapeutics Corp., a clinical-stage biotechnology company, focuses on the discovery, research, and development of treatments for central nervous system (CNS) disorders, RASopathies, and cancers. Its lead product candidate is PAS-004, a next-generation macrocyclic mitogen-activated protein kinase, or MEK inhibitor to treat a range of RASopathies, including neurofibromatosis type 1 (NF1); MAPK pathway-driven tumors, such as BRAFv600 and BRAF fusion tumors; and ETS2 driven diseases, including inflammatory bowel disease (IBD), primary sclerosing cholangitis, and ankylosing spondylitis. The company's lead development candidate is PAS-003, to treat amyotrophic lateral sclerosis. It also intends to develop PAS-001, to treat schizophrenia. Pasithea Therapeutics Corp. was incorporated in 2020 and is headquartered in Miami Beach, Florida.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Biotechnology Market Cap 17.75M
Enterprise Value -37.38M Income -20.43M Sales —
Book/sh 2.39 Cash/sh 2.39 Dividend Yield —
Payout 0.00% Employees — IPO —
P/E — Forward P/E -0.37 PEG —
P/S — P/B 0.32 P/C —
EV/EBITDA 1.89 EV/Sales — Quick Ratio 11.09
Current Ratio 11.35 Debt/Eq — LT Debt/Eq —
EPS (ttm) -2.91 EPS next Y -2.10 EPS Growth —
Revenue Growth — Earnings 2026-03-30 17:00 ROA -33.54%
ROE -58.36% ROIC — Gross Margin 0.00%
Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand 23.09M
Shs Float 14.90M Short Float 0.86% Short Ratio 1.61
Short Interest — 52W High 3.79 52W Low 0.28
Beta — Avg Volume 282.56K Volume 58.82K
Target Price $3.00 Recom Strong_buy Prev Close $0.77
Price $0.77 Change -0.16%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$3.00
Mean price target
2. Current target
$0.79
Latest analyst target
3. DCF / Fair value
$-7.12
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.79
Low
$3.00
High
$3.00
Mean
$3.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-12-08 init HC Wainwright & Co. — → Buy $3
News
RSS: Latest KTTA news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-11-28 SCHNEIDERMAN DANIEL H Chief Financial Officer — 26,667 $1.47 $39,200
2025-11-28 LEAHY EMER Director — 33,333 $1.47 $49,000
2025-11-28 STEINMAN LAWRENCE Director — 133,333 $1.47 $196,000
2025-11-28 MARQUES TIAGO REIS Chief Executive Officer — 33,333 $1.47 $49,000
2025-11-28 DUMESNIL SIMON Director — 33,333 $1.47 $49,000
2025-05-12 MARQUES TIAGO REIS Chief Executive Officer — 960 $0.82 $792
2024-06-13 NOVAK ALFRED J Director — 3,500 $5.61 $19,662
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Cost Of Revenue
—
—
—
0.11
Reconciled Cost Of Revenue
—
—
—
0.11
Gross Profit
—
—
—
0.37
Operating Expense
20.86
+46.37%
14.25
-10.82%
15.98
+26.93%
12.59
Research And Development
7.98
+10.87%
7.20
-11.14%
8.10
+203.92%
2.67
Selling General And Administration
12.88
+82.60%
7.05
-10.50%
7.88
-20.61%
9.92
General And Administrative Expense
12.88
+82.60%
7.05
-10.50%
7.88
-20.61%
9.92
Other Gand A
12.88
+82.60%
7.05
-10.50%
7.88
-20.61%
9.92
Total Expenses
20.86
+46.37%
14.25
-10.82%
15.98
+26.93%
12.59
Operating Income
-20.86
-46.37%
-14.25
+10.82%
-15.98
-26.93%
-12.59
Total Operating Income As Reported
-20.86
-46.37%
-14.25
+10.82%
-15.98
-26.93%
-12.59
EBITDA
-20.19
-48.48%
-13.60
+11.28%
-15.33
-21.83%
-12.58
Normalized EBITDA
-19.92
-47.28%
-13.52
+12.11%
-15.39
-14.54%
-13.43
Reconciled Depreciation
0.66
+2.09%
0.65
+0.09%
0.65
+12629.76%
0.01
EBIT
-20.86
-46.37%
-14.25
+10.82%
-15.98
-26.93%
-12.59
Total Unusual Items
-0.28
-257.44%
-0.08
-238.33%
0.06
-93.39%
0.85
Total Unusual Items Excluding Goodwill
-0.28
-257.44%
-0.08
-238.33%
0.06
-93.39%
0.85
Special Income Charges
—
—
0.00
+100.00%
-1.00
Other Special Charges
—
—
—
1.00
Net Income
-20.43
-46.91%
-13.90
+12.89%
-15.96
-14.53%
-13.94
Pretax Income
-20.43
-46.91%
-13.90
+10.34%
-15.51
-32.23%
-11.73
Net Non Operating Interest Income Expense
0.33
-22.68%
0.42
+1.88%
0.42
0.00
Interest Expense Non Operating
—
—
—
0.00
Net Interest Income
0.33
-22.68%
0.42
+1.88%
0.42
0.00
Interest Expense
—
—
—
0.00
Interest Income Non Operating
0.33
-22.68%
0.42
+1.88%
0.42
0.00
Interest Income
0.33
-22.68%
0.42
+1.88%
0.42
0.00
Other Income Expense
0.10
+231.63%
-0.08
-238.33%
0.06
-93.47%
0.86
Other Non Operating Income Expenses
0.38
—
—
0.01
Gain On Sale Of Security
-0.28
-257.44%
-0.08
-238.33%
0.06
-96.96%
1.85
Tax Provision
0.00
0.00
0.00
0.00
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-20.43
-46.91%
-13.90
+12.89%
-15.96
-14.53%
-13.94
Net Income From Continuing Operation Net Minority Interest
-20.43
-46.91%
-13.90
+10.34%
-15.51
-32.23%
-11.73
Net Income From Continuing And Discontinued Operation
-20.43
-46.91%
-13.90
+12.89%
-15.96
-14.53%
-13.94
Net Income Continuous Operations
-20.43
-46.91%
-13.90
+10.34%
-15.51
-32.23%
-11.73
Net Income Discontinuous Operations
—
0.00
+100.00%
-0.45
+79.45%
-2.21
Normalized Income
-20.15
-45.73%
-13.83
+11.16%
-15.56
-23.74%
-12.58
Net Income Common Stockholders
-20.43
-46.91%
-13.90
+12.89%
-15.96
-14.53%
-13.94
Diluted EPS
—
-12.69
+2.46%
-13.01
-17.95%
-11.03
Basic EPS
—
-12.69
+2.46%
-13.01
-17.95%
-11.03
Basic Average Shares
—
1.10
-10.64%
1.23
-2.83%
1.26
Diluted Average Shares
—
1.10
-10.64%
1.23
-2.83%
1.26
Diluted NI Availto Com Stockholders
-20.43
-46.91%
-13.90
+12.89%
-15.96
-14.53%
-13.94
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
60.24
+274.98%
16.06
-38.49%
26.12
-42.19%
45.18
Current Assets
56.46
+666.24%
7.37
-55.86%
16.69
-51.02%
34.08
Cash Cash Equivalents And Short Term Investments
55.16
+696.78%
6.92
-57.61%
16.33
-50.64%
33.09
Cash And Cash Equivalents
55.16
+696.78%
6.92
-57.61%
16.33
-50.64%
33.09
Cash Equivalents
53.40
+775.41%
6.10
-54.48%
13.40
—
Cash Financial
1.76
+113.79%
0.82
-71.93%
2.93
-91.16%
33.15
Receivables
—
0.00
-100.00%
0.04
0.00
Other Receivables
—
—
0.04
-86.60%
0.30
Prepaid Assets
0.81
+168.12%
0.30
+40.18%
0.22
-61.61%
0.56
Restricted Cash
0.10
0.00
—
—
Assets Held For Sale Current
—
—
0.00
-100.00%
0.16
Other Current Assets
0.39
+171.31%
0.14
+36.52%
0.10
-60.19%
0.26
Total Non Current Assets
3.78
-56.52%
8.70
-7.73%
9.42
-15.12%
11.10
Net PPE
0.00
-100.00%
0.12
-44.51%
0.22
-64.76%
0.63
Gross PPE
0.00
-100.00%
0.16
-32.49%
0.24
-61.22%
0.63
Accumulated Depreciation
0.00
+100.00%
-0.04
-80.32%
-0.02
-559.96%
-0.00
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
0.00
-100.00%
0.01
+0.00%
0.01
-76.69%
0.03
Other Properties
—
0.16
-33.78%
0.23
-60.87%
0.60
Leases
0.00
-100.00%
0.00
+0.00%
0.00
+0.00%
0.00
Goodwill And Other Intangible Assets
3.78
-55.90%
8.57
-6.85%
9.20
-6.41%
9.83
Goodwill
0.00
-100.00%
1.26
+0.00%
1.26
+0.00%
1.26
Other Intangible Assets
3.78
-48.28%
7.31
-7.94%
7.94
-7.35%
8.57
Other Non Current Assets
—
—
—
0.64
Total Liabilities Net Minority Interest
5.02
+291.63%
1.28
-52.84%
2.72
+1.36%
2.68
Current Liabilities
4.97
+344.15%
1.12
-57.48%
2.63
+40.29%
1.88
Payables And Accrued Expenses
1.13
+1.00%
1.12
-56.12%
2.55
+72.29%
1.48
Current Debt And Capital Lease Obligation
—
—
0.08
-49.07%
0.16
Current Capital Lease Obligation
—
0.00
-100.00%
0.08
-49.07%
0.16
Other Current Liabilities
3.84
—
—
0.24
Total Non Current Liabilities Net Minority Interest
0.05
-71.10%
0.16
+92.22%
0.08
-89.51%
0.80
Liabilities Heldfor Sale Non Current
—
—
0.00
-100.00%
0.32
Long Term Debt And Capital Lease Obligation
—
—
0.00
-100.00%
0.34
Long Term Capital Lease Obligation
—
—
0.00
-100.00%
0.34
Stockholders Equity
55.22
+273.54%
14.78
-36.82%
23.40
-44.94%
42.50
Common Stock Equity
55.22
+273.54%
14.78
-36.82%
23.40
-44.94%
42.50
Capital Stock
0.00
+1561.15%
0.00
+33.65%
0.00
-20.00%
0.00
Common Stock
0.00
+1561.15%
0.00
+33.65%
0.00
-20.00%
0.00
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
23.09
+1556.15%
1.39
+33.86%
1.04
-20.01%
1.30
Ordinary Shares Number
23.09
+1556.15%
1.39
+33.86%
1.04
-20.01%
1.30
Additional Paid In Capital
125.21
+94.51%
64.37
+9.62%
58.72
-5.07%
61.86
Retained Earnings
-70.01
-41.20%
-49.58
-40.39%
-35.32
-82.46%
-19.36
Gains Losses Not Affecting Retained Earnings
0.02
+361.69%
-0.01
-54.15%
-0.00
-603.78%
-0.00
Other Equity Adjustments
0.02
+361.69%
-0.01
-54.15%
-0.00
-603.78%
-0.00
Total Equity Gross Minority Interest
55.22
+273.54%
14.78
-36.82%
23.40
-44.94%
42.50
Total Capitalization
55.22
+273.54%
14.78
-36.82%
23.40
-44.94%
42.50
Working Capital
51.49
+723.97%
6.25
-55.55%
14.06
-56.34%
32.20
Invested Capital
55.22
+273.54%
14.78
-36.82%
23.40
-44.94%
42.50
Total Debt
—
0.00
-100.00%
0.08
-83.81%
0.50
Capital Lease Obligations
—
0.00
-100.00%
0.08
-83.81%
0.50
Net Tangible Assets
51.44
+728.50%
6.21
-56.26%
14.19
-56.54%
32.66
Tangible Book Value
51.44
+728.50%
6.21
-56.26%
14.19
-56.54%
32.66
Derivative Product Liabilities
0.05
-71.10%
0.16
+92.22%
0.08
-40.00%
0.14
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-15.21
-9.25%
-13.92
-3.71%
-13.43
+1.94%
-13.69
Cash Flow From Continuing Operating Activities
-15.21
-9.25%
-13.92
-8.66%
-12.81
-7.73%
-11.89
Cash From Discontinued Operating Activities
—
0.00
+100.00%
-0.61
+65.98%
-1.80
Net Income From Continuing Operations
-20.43
-46.91%
-13.90
+10.34%
-15.51
-32.23%
-11.73
Depreciation Amortization Depletion
0.66
+2.09%
0.65
+0.09%
0.65
+12629.76%
0.01
Depreciation
0.03
+71.86%
0.02
+3.14%
0.02
+259.05%
0.01
Amortization Cash Flow
0.63
+0.00%
0.63
+0.00%
0.63
0.00
Depreciation And Amortization
0.66
+2.09%
0.65
+0.09%
0.65
+12629.76%
0.01
Amortization Of Intangibles
0.63
+0.00%
0.63
+0.00%
0.63
0.00
Other Non Cash Items
—
—
—
0.36
Stock Based Compensation
0.30
-61.55%
0.77
+30.63%
0.59
-29.08%
0.84
Asset Impairment Charge
4.16
0.00
—
0.42
Operating Gains Losses
0.41
+429.28%
0.08
+164.15%
-0.12
+93.45%
-1.85
Gain Loss On Investment Securities
0.30
+287.27%
0.08
+238.33%
-0.06
+96.96%
-1.85
Net Foreign Currency Exchange Gain Loss
0.01
0.00
—
—
Change In Working Capital
-0.32
+79.03%
-1.52
-196.52%
1.57
+86.22%
0.85
Change In Prepaid Assets
-0.06
+30.21%
-0.09
-125.04%
0.35
+291.03%
-0.18
Change In Payables And Accrued Expense
0.01
+100.78%
-1.43
-233.76%
1.07
+43.61%
0.75
Change In Other Current Assets
-0.27
-12004.42%
0.00
-98.57%
0.16
+160.19%
-0.26
Change In Other Current Liabilities
0.00
+100.00%
-0.00
-55.72%
-0.00
-100.28%
0.54
Investing Cash Flow
0.01
0.00
-100.00%
0.40
+113.63%
-2.93
Cash Flow From Continuing Investing Activities
0.01
0.00
-100.00%
0.08
+103.27%
-2.30
Cash From Discontinued Investing Activities
—
0.00
-100.00%
0.32
+151.65%
-0.63
Net PPE Purchase And Sale
0.01
0.00
+100.00%
-0.03
+67.97%
-0.11
Purchase Of PPE
—
0.00
+100.00%
-0.03
+67.97%
-0.11
Sale Of PPE
0.01
0.00
—
—
Capital Expenditure
—
—
-0.03
+67.97%
-0.11
Net Business Purchase And Sale
—
—
0.00
+100.00%
-2.19
Purchase Of Business
—
—
0.00
+100.00%
-2.19
Net Intangibles Purchase And Sale
—
—
—
-1.76
Purchase Of Intangibles
—
—
—
-1.76
Net Other Investing Changes
—
—
0.11
—
Financing Cash Flow
63.52
+1306.02%
4.52
+221.23%
-3.73
-16.22%
-3.21
Cash Flow From Continuing Financing Activities
63.52
+1306.02%
4.52
+221.23%
-3.73
-16.22%
-3.21
Net Issuance Payments Of Debt
—
0.00
0.00
0.00
Issuance Of Debt
—
0.00
-100.00%
0.39
0.00
Repayment Of Debt
—
0.00
+100.00%
-0.39
0.00
Long Term Debt Issuance
—
0.00
-100.00%
0.39
0.00
Long Term Debt Payments
—
0.00
+100.00%
-0.39
0.00
Net Long Term Debt Issuance
—
0.00
0.00
0.00
Net Common Stock Issuance
61.72
0.00
+100.00%
-3.73
-16.22%
-3.21
Common Stock Payments
—
0.00
+100.00%
-3.73
-16.22%
-3.21
Repurchase Of Capital Stock
—
0.00
+100.00%
-3.73
-16.22%
-3.21
Proceeds From Stock Option Exercised
2.25
-50.20%
4.52
0.00
0.00
Net Other Financing Charges
-0.45
+6.90%
-0.48
—
—
Changes In Cash
48.32
+613.71%
-9.41
+43.86%
-16.75
+15.49%
-19.82
Effect Of Exchange Rate Changes
0.02
+844.98%
-0.00
+36.88%
-0.00
-140.31%
0.01
Beginning Cash Position
6.92
-57.61%
16.33
-50.64%
33.09
-37.45%
52.90
End Cash Position
55.26
+698.24%
6.92
-57.61%
16.33
-50.64%
33.09
Free Cash Flow
-15.21
-9.25%
-13.92
-3.45%
-13.46
+2.45%
-13.80
Interest Paid Supplemental Data
0.01
0.00
—
—
Income Tax Paid Supplemental Data
0.00
0.00
—
—
Common Stock Issuance
61.72
0.00
—
0.00
Issuance Of Capital Stock
61.72
0.00
—
0.00
Sale Of Business
—
—
—
0.08
Cash From Discontinued Financing Activities
—
0.00
0.00
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category